Atai Beckley/$ATAI
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Atai Beckley
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Ticker
$ATAI
Sector
Primary listing
Employees
54
Headquarters
Website
Atai Beckley Metrics
BasicAdvanced
$1.5B
-
-$0.82
1.62
-
Price and volume
Market cap
$1.5B
Beta
1.62
Financial strength
Current ratio
7.898
Quick ratio
6.988
Long term debt to equity
3.081
Total debt to equity
3.413
Interest coverage (TTM)
-23.40%
Profitability
EBITDA (TTM)
-101.424
Gross margin (TTM)
-1,116.04%
Net profit margin (TTM)
-5,109.08%
Operating margin (TTM)
-3,324.22%
Effective tax rate (TTM)
0.27%
Revenue per employee (TTM)
$60,000
Management effectiveness
Return on assets (TTM)
-28.67%
Return on equity (TTM)
-100.78%
Valuation
Price to revenue (TTM)
249.05
Price to book
6.02
Price to tangible book (TTM)
6.15
Price to free cash flow (TTM)
-9.015
Free cash flow yield (TTM)
-11.09%
Free cash flow per share (TTM)
-0.444
Growth
Revenue change (TTM)
811.78%
Earnings per share change (TTM)
3.25%
3-year revenue growth (CAGR)
92.21%
3-year earnings per share growth (CAGR)
-13.73%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Atai Beckley stock?
Atai Beckley (ATAI) has a market cap of $1.5B as of January 07, 2026.
What is the P/E ratio for Atai Beckley stock?
The price to earnings (P/E) ratio for Atai Beckley (ATAI) stock is 0 as of January 07, 2026.
Does Atai Beckley stock pay dividends?
No, Atai Beckley (ATAI) stock does not pay dividends to its shareholders as of January 07, 2026.
When is the next Atai Beckley dividend payment date?
Atai Beckley (ATAI) stock does not pay dividends to its shareholders.
What is the beta indicator for Atai Beckley?
Atai Beckley (ATAI) has a beta rating of 1.62. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.